MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Inc. (NEUP)

||
||

Cash Flow Overview

Change in Cash
$5,576,841
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from the sale of equity...
    • Goodwill impairment
    • Depreciation and amortization ex...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Accrued expenses and other curre...
    • Change in fair value of accompan...
    • Others
Cash Flow
2026-06-30
2025-06-30
Net loss
-13,451,931
-369,632
Share-based compensation
351,600
163,772
Goodwill impairment
5,362,000
-
Depreciation and amortization expense
662,955
662,890
Non-cash rent expense
-102,612
-114,363
Change in fair value of accompanying warrant liability
-1,730,321
-956,340
Change in fair value of contingent consideration
-198,888
716,654
Effect of foreign currency remeasurement
-603,313
-242,348
Accounts receivable, non-trade
801,483
-114,936
Prepaid expenses
-350,421
453,058
Accounts payable
-768,785
-917,663
Accrued expenses and other current liabilities
-2,579,080
1,486,656
Operating lease liabilities
-116,314
-123,304
Deferred tax liability
-139,173
-468,427
Contingent consideration
-
-133,080
Other non-current liabilities
-
-2,886
Net cash (used in) provided by operating activities
-12,353,074
77,229
Proceeds from the sale of equity, net of subscriptions receivable and issuance costs
17,915,883
1,528,276
Net cash provided by financing activities
17,915,883
1,528,276
Effect of exchange rate on changes in cash, cash equivalents, and restricted cash
14,032
-3,750
Net increase in cash, cash equivalents, and restricted cash
5,576,841
1,601,755
Cash, cash equivalents, and restricted cash, beginning of period
14,288,690
12,686,935
Cash, cash equivalents, and restricted cash, end of period
19,865,531
14,288,690
Cash and cash equivalents
19,865,531
-
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

NEUP Cash Flow Sankey DiagramSankey diagram visualizing NEUP cash flow for the periodProceeds from the sale ofequity, net of...$17,915,883 (1072.29%↑ Y/Y)Net cash provided byfinancing activities$17,915,883 (1072.29%↑ Y/Y)Effect of exchange rateon changes in cash,...$14,032 (474.19%↑ Y/Y)Net increase incash, cash...$5,576,841 (248.17%↑ Y/Y)Canceled cashflow$12,353,074 Goodwill impairment$5,362,000 Depreciation andamortization expense$662,955 (0.01%↑ Y/Y)Effect of foreigncurrency remeasurement-$603,313 (-148.94%↓ Y/Y)Share-based compensation$351,600 (114.69%↑ Y/Y)Prepaid expenses-$350,421 (-177.35%↓ Y/Y)Non-cash rent expense-$102,612 (10.28%↑ Y/Y)Net cash (used in)provided by operating...-$12,353,074 (-16095.38%↓ Y/Y)Canceled cashflow$7,432,901 Net loss-$13,451,931 (-3539.28%↓ Y/Y)Accrued expenses andother current...-$2,579,080 (-273.48%↓ Y/Y)Change in fair value ofaccompanying warrant...-$1,730,321 (-80.93%↓ Y/Y)Accounts receivable,non-trade$801,483 (797.33%↑ Y/Y)Accounts payable-$768,785 (16.22%↑ Y/Y)Change in fair value ofcontingent consideration-$198,888 (-127.75%↓ Y/Y)Deferred tax liability-$139,173 (70.29%↑ Y/Y)Operating leaseliabilities-$116,314 (5.67%↑ Y/Y)